ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,143Medicare Part D Prescriptions Filled, Including Refills

Rank: 327 out of 1677

$586K Total Retail Price of All Prescriptions

Rank: 267 out of 1677

397 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 397 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 397 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,719 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
NAMENDA 331 300 1 39
HYDROCODONE-ACETAMINOPHEN 314 272 S3 2 4
DONEPEZIL HCL 266 243 3 30
LISINOPRIL 258 217 4 3
TRAMADOL HCL 253 210 5 16
LEVOTHYROXINE SODIUM 245 220 6 5
OMEPRAZOLE 236 173 7 6
FUROSEMIDE 229 212 8 8
ATORVASTATIN CALCIUM 195 180 9 13
SIMVASTATIN 187 153 10 1
CITALOPRAM HBR 186 161 11 22
AMLODIPINE BESYLATE 178 160 12 2
MELOXICAM 157 140 13 27
METOPROLOL TARTRATE 155 96 14 12
RANITIDINE HCL 153 130 15 18
GABAPENTIN 151 146 16 11
TAMSULOSIN HCL 135 120 17 34
SERTRALINE HCL 134 121 18 26
POTASSIUM CHLORIDE 132 127 19 14
MIRTAZAPINE 111 76 20 62
ZOLPIDEM TARTRATE 103 96 21 15
LANTUS 102 90 22 44
DIVALPROEX SODIUM 101 86 23 111
CARVEDILOL 99 86 24 20
LEVOFLOXACIN 97 90 25 84
PANTOPRAZOLE SODIUM 96 91 26 46
PREDNISONE 94 83 27 40
DOXYCYCLINE HYCLATE 90 78 28 96
GLIPIZIDE ER 88 84 29 78
KLOR-CON M20 88 67 29 65
AZITHROMYCIN 79 67 31 38
FLUTICASONE PROPIONATE 78 71 32 29
QUETIAPINE FUMARATE 77 68 33 77
CIPROFLOXACIN HCL 77 70 33 57
PLAVIX 73 61 35 47
RISPERIDONE 73 66 35 60
NOVOLOG 72 61 37 117
ESCITALOPRAM OXALATE 72 50 37 80
NITROFURANTOIN MONO-MACRO 71 64 39 177
CLOPIDOGREL 70 55 40 32
ALLOPURINOL 69 57 41 31
CEPHALEXIN 69 60 41 99
TRAZODONE HCL 68 50 43 37
CEFTRIAXONE 67 43 44 242
METOPROLOL SUCCINATE 66 66 45 23
WARFARIN SODIUM 64 64 46 24
PRAVASTATIN SODIUM 63 52 47 10
HYDROCHLOROTHIAZIDE 56 52 48 9
SPIRIVA 54 53 49 74
DILT-XR 53 44 50 409
CYMBALTA 53 53 50 58
MUPIROCIN 51 45 52 170
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.